TY - JOUR
T1 - Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients
AU - Morath, Christian
AU - Hayek, Salim S.
AU - Döhler, Bernd
AU - Nusshag, Christian
AU - Sommerer, Claudia
AU - Zeier, Martin
AU - Reiser, Jochen
AU - Süsal, Caner
N1 - Publisher Copyright:
Copyright © 2022 Morath, Hayek, Döhler, Nusshag, Sommerer, Zeier, Reiser and Süsal.
PY - 2022/2/3
Y1 - 2022/2/3
N2 - Main problem: Soluble urokinase plasminogen activator receptor (suPAR) is an immunological risk factor for kidney disease and a prognostic marker for cardiovascular events. Methods: We measured serum suPAR levels in a total of 1,023 kidney transplant recipients either before (cohort 1, n = 474) or at year 1 after transplantation (cohort 2, n = 549). The association of suPAR levels and all-cause and cardiovascular mortality was evaluated by multivariable Cox regression analysis. Results: The highest suPAR tertile compared to the two lower tertiles had a significantly higher risk of all-cause mortality in both cohorts separately (cohort 1: hazard ratio (HR) 1.92, 95% confidence interval (CI) 1.20–3.08, p = 0.007; cohort 2: HR = 2.78, 95% CI 1.51–5.13, p = 0.001) and combined (n = 1,023, combined HR = 2.14, 95% CI 1.48–3.08, p < 0.001). The association remained significant in the subgroup of patients with normal kidney function (cohort 2: HR = 5.40, 95% CI 1.42–20.5, p = 0.013). The increased mortality risk in patients with high suPAR levels was attributable mainly to an increased rate of cardiovascular death (n = 1,023, HR = 4.24, 95% CI 1.81–9.96, p < 0.001). Conclusion: A high suPAR level prior to and at 1 year after kidney transplantation was associated with an increased risk of patient death independent of kidney function, predominantly from cardiovascular cause.
AB - Main problem: Soluble urokinase plasminogen activator receptor (suPAR) is an immunological risk factor for kidney disease and a prognostic marker for cardiovascular events. Methods: We measured serum suPAR levels in a total of 1,023 kidney transplant recipients either before (cohort 1, n = 474) or at year 1 after transplantation (cohort 2, n = 549). The association of suPAR levels and all-cause and cardiovascular mortality was evaluated by multivariable Cox regression analysis. Results: The highest suPAR tertile compared to the two lower tertiles had a significantly higher risk of all-cause mortality in both cohorts separately (cohort 1: hazard ratio (HR) 1.92, 95% confidence interval (CI) 1.20–3.08, p = 0.007; cohort 2: HR = 2.78, 95% CI 1.51–5.13, p = 0.001) and combined (n = 1,023, combined HR = 2.14, 95% CI 1.48–3.08, p < 0.001). The association remained significant in the subgroup of patients with normal kidney function (cohort 2: HR = 5.40, 95% CI 1.42–20.5, p = 0.013). The increased mortality risk in patients with high suPAR levels was attributable mainly to an increased rate of cardiovascular death (n = 1,023, HR = 4.24, 95% CI 1.81–9.96, p < 0.001). Conclusion: A high suPAR level prior to and at 1 year after kidney transplantation was associated with an increased risk of patient death independent of kidney function, predominantly from cardiovascular cause.
KW - cardiovascular
KW - kidney
KW - mortality
KW - suPAR
KW - transplantation
UR - http://www.scopus.com/inward/record.url?scp=85124823084&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124823084&partnerID=8YFLogxK
U2 - 10.3389/ti.2021.10071
DO - 10.3389/ti.2021.10071
M3 - Article
C2 - 35185364
AN - SCOPUS:85124823084
SN - 0934-0874
VL - 35
JO - Transplant International
JF - Transplant International
M1 - 10071
ER -